Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NATR
NATR logo

NATR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nature's Sunshine Products Inc (NATR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
24.230
1 Day change
-1.30%
52 Week Range
28.140
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Nature's Sunshine Products Inc (NATR) does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. While the stock has received positive analyst ratings and price target increases, the company's financial performance shows significant challenges, including a sharp decline in net income and EPS. Additionally, insider selling activity and mixed news sentiment further weaken the case for immediate investment. The technical indicators are neutral to slightly bullish, but without strong proprietary trading signals or compelling catalysts, holding off on purchasing is recommended.

Technical Analysis

The technical indicators show a slightly bullish trend with MACD above 0 and positively contracting, RSI in the neutral zone at 58.728, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its pivot level (26.712), with resistance at 27.338 and support at 26.086, suggesting limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • Analysts have raised price targets to $33, reflecting confidence in the company's growth potential.

  • Revenue increased by 4.74% YoY in Q4 2025, showing some growth momentum.

Neutral/Negative Catalysts

  • Insider selling has increased by 161.97% over the last month, signaling potential lack of confidence from insiders.

  • Net income dropped significantly by -1379.44% YoY, and EPS declined by -1250.00% YoY in Q4 2025, highlighting financial struggles.

  • News sentiment is mixed, with concerns about limited distribution channels and low operating margins.

Financial Performance

In Q4 2025, revenue increased by 4.74% YoY to $123.8M, but net income dropped by -1379.44% YoY to $4.1M, and EPS fell by -1250.00% YoY to $0.23. Gross margin improved slightly to 72.52%, up 0.78% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have consistently raised price targets, with the latest targets at $33, up from $23 and $29 earlier. Analysts maintain a Buy rating, citing strong growth in digital business and under-penetrated markets. However, the company's financial struggles and mixed future prospects temper the optimism.

Wall Street analysts forecast NATR stock price to fall
2 Analyst Rating
Wall Street analysts forecast NATR stock price to fall
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 24.550
sliders
Low
22
Averages
22.5
High
23
Current: 24.550
sliders
Low
22
Averages
22.5
High
23
Canaccord
Buy
maintain
$33 -> $37
AI Analysis
2026-05-08
New
Reason
Canaccord
Price Target
$33 -> $37
AI Analysis
2026-05-08
New
maintain
Buy
Reason
Canaccord raised the firm's price target on Nature's Sunshine to $37 from $33 and keeps a Buy rating on the shares. The firm said they reported better than expected Q1 results. Management highlighted plans to enter Germany and expand into two new high-value Asian markets using the Synergy Asia sales system. Management also noted they are rolling out the Synergy brand to the U.S. market through affiliates that know the brand well in Asia.
DA Davidson
Buy
maintain
$23 -> $33
2026-03-12
Reason
DA Davidson
Price Target
$23 -> $33
2026-03-12
maintain
Buy
Reason
DA Davidson raised the firm's price target on Nature's Sunshine to $33 from $23 and keeps a Buy rating on the shares. The company's beat and raise trend continues with Q4 results comfortably above consensus forecasts, and the firm sees further upward revisions as results underscore the extent to which the company's portfolio is under-penetrated across key markets, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NATR
Unlock Now

People Also Watch